–
IRulya Therapeutics Inc. (QNCX)
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
0
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−90.3
FY22:
−52.0
FY23:
−34.6
FY24:
−57.3
FY25:
−58.1
(positive)
millions USD
FY21:
−90.0
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−89.9
FY22:
−51.9
FY23:
−31.6
FY24:
−56.7
FY25:
−80.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−89.9
FY22:
−51.7
FY23:
−31.4
FY24:
−56.8
FY25:
−84.0
All amounts in millions USD